Billboard Chris
Donner

Obtenez les faits · Mythe du suicide

Faits sur le suicide

La menace du suicide est la tactique numéro un que des médecins activistes, des politiciens et des organismes médicaux utilisent depuis des années pour acheter du soutien à la transition des enfants.

On dit même aux parents qu’ils peuvent avoir une fille morte ou un fils vivant. C’est de la manipulation coercitive et un mensonge méprisable.

Les faits sont là. Le suicide complété est, heureusement, rare, et on n’a pas démontré que la transition médicale pédiatrique prévient le suicide.

Les études

Lisez le graphique, pas un mur de liens. Les études sur les jeunes ne sont pas des études sur les adultes. Un sondage sur les tentatives de suicide n’est pas un décompte des décès par suicide.

Tableau 4.1 du HHS : mortalité par suicide chez les jeunes adressés à des cliniques de « médecine de genre » pédiatrique, avec des taux estimés pour 1 000 années-patients.
Tableau 4.1, HHS Treatment for Pediatric Gender Dysphoria (2025). Rapport du HHS (PDF) →

News — Supreme Court exchange

ACLU Attorney Confesses: Transgender-Suicide Claim is a Myth (City Journal)

In U.S. v. Skrmetti oral argument (Dec 4, 2024), ACLU attorney Chase Strangio told Justice Alito there is no evidence in the studies that gender-affirming treatment reduces completed suicide, and that completed suicide is “thankfully and admittedly” rare — while distinguishing that from “suicidality.”

City Journal →

Constatations liées au suicide de Biggs (2022), Van Cauwenberg (2021), Ruuska (2024), Do No Harm, Cass, HHS et Dhejne 2011

Étude

Biggs (2022) — Suicide by Clinic-Referred Transgender Adolescents in the United Kingdom. Arch Sex Behav.

Tavistock GIDS referrals, 2010–2020.

Constatation

Among ~15,032 youth referred to Tavistock GIDS (2010–2020), 4 suicides — completed suicide rare in absolute terms (HHS Table 4.1: 0.03%, 0.13 per 1K patient-years).

Étude

Van Cauwenberg et al. (2021) — Ten years of experience in counseling gender diverse youth in Flanders, Belgium

Belgian pediatric gender clinic cohort.

Constatation

Belgian pediatric gender clinic cohort; 5 suicides among referred youths (HHS Table 4.1: 3.38%, 11.26 per 1K patient-years); HHS notes all suicides among patients taking cross-sex hormones.

Étude

Finland — Ruuska et al. (2024)

Youth and young adults under 23 referred to Finnish gender services, 1996–2019: 2,083 people vs 16,643 matched controls.

Constatation

Suicide deaths were uncommon (0.3% vs 0.1% in matched peers) and, once specialist psychiatric treatment was accounted for, not statistically different; medical gender reassignment was not shown to change suicide risk.

Étude

Do No Harm — Greene & Kingsbury (17 September 2026)

New — 17 September 2026

CDC teen suicide rates after state bans on puberty blockers, opposite-sex hormones, and surgeries for minors. Jay Greene, Ph.D. and Ian Kingsbury, Ph.D. for Do No Harm. Three models: difference-in-differences, Callaway–Sant’Anna DiD, and a national time-series.

Constatation

Do No Harm analyzed CDC teen suicide rates after state bans on puberty blockers, opposite-sex hormones, and surgeries for minors. Across three models (difference-in-differences, Callaway–Sant’Anna DiD, and a national time-series), there was no statistically significant increase in teen suicide rates. The claim that these bans cause a spike in teen suicides is not supported by the data.

Étude

Cass Review (2024)

Independent review of NHS gender identity services for children and young people, underpinned by University of York systematic reviews.

Constatation

The evidence does not support the claim that hormone treatment reduces the elevated risk of death by suicide in this population.

Étude

HHS evidence review (November 2025)

U.S. Department of Health and Human Services review of treatment for pediatric gender dysphoria. The suicide points on this chart are from that review.

Constatation

There is no evidence that pediatric medical transition reduces suicide deaths, which remain very low; completed suicide among adolescents with gender dysphoria is rare, and suicidality tracks with other mental-health conditions rather than with gender dysphoria alone.

Étude

Dhejne et al. (2011) — Long-Term Follow-Up of Transsexual Persons Undergoing Sex Reassignment Surgery: Cohort Study in Sweden. PLOS ONE.

Adults. All 324 people in Sweden who had sex-reassignment surgery, 1973–2003, compared with matched population controls.

Constatation

After sex reassignment / surgical transition, suicide deaths were about 19.1 times higher than among matched peers (adjusted hazard ratio 19.1). Transition did not bring suicide mortality in line with the general population — the elevated suicide risk remained after transition.

L’ancienne page web de GIDS « Evidence base » n’existe plus, donc ce n’est pas une source ici. Le suivi officiel du Royaume-Uni est le rapport Appleby de 2024 sur les suicides de Tavistock / GIDS : les données n’appuient pas une forte hausse après la restriction des bloqueurs de puberté. Appleby 2024 — Tavistock / GIDS suicides (GOV.UK) →

Abonnez-vous. Recevez les mises à jour.

Nouvelles, victoires juridiques et outils pour dire la vérité — une conversation à la fois.

Choisissez un courriel quotidien, un bilan hebdomadaire, ou les deux.

Fréquence des courriels

Choisissez-en un ou les deux.